Our results suggest DARPP-32 and t-DARPP promote NSCLC cell survival through activation of Akt and Erk1/2 signaling by protecting cells from apoptotic cell death (Figs. 1 and 2 and Supplementary Fig. 1). Here, AKT1 is linked to non-small cell lung carcinoma.